Viewing StudyNCT06333509

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:19 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06333509
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-27
First Post: 2024-02-19
Brief Title: Anti-GPRC5D CAR-T Cells CT071 in Participants With RRMM or RRpPCL
Sponsor: CARsgen Therapeutics Co Ltd
Organization: CARsgen Therapeutics Co Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Primary Plasma Cell Leukemia
Multiple Myeloma
Keywords:
Name View
hematologic cancer View
CAR-T View
Multiple Myeloma View
Primary plasma cell myeloma View
CT071 View
GPRC5D View
anti-GPRC5D View
genetically modified T-cells View